Nannan Shi

3.9k total citations · 2 hit papers
51 papers, 1.8k citations indexed

About

Nannan Shi is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Complementary and alternative medicine. According to data from OpenAlex, Nannan Shi has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Public Health, Environmental and Occupational Health and 10 papers in Complementary and alternative medicine. Recurrent topics in Nannan Shi's work include COVID-19 Clinical Research Studies (12 papers), Clinical practice guidelines implementation (9 papers) and Long-Term Effects of COVID-19 (7 papers). Nannan Shi is often cited by papers focused on COVID-19 Clinical Research Studies (12 papers), Clinical practice guidelines implementation (9 papers) and Long-Term Effects of COVID-19 (7 papers). Nannan Shi collaborates with scholars based in China, Hong Kong and United States. Nannan Shi's co-authors include Fei Shan, Fengxiang Song, Yuxin Shi, Hongzhou Lu, Zhiyong Zhang, Jie Shen, Yun Ling, Yebin Jiang, Ning Liang and Yuxin Shi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Radiology and Frontiers in Immunology.

In The Last Decade

Nannan Shi

48 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia

2020 865 citations Fengxiang Song, Nannan Shi et al. profile →
Resistant starch and the gut microbiome: Exploring beneficial interactions and dietary impacts

2024 48 citations Chen Zhao, Ning Liang et al. profile →

Peers

Nannan Shi

RNMI

NEURO

ONCOL

Rui Han China

Joseph E. Ebinger United States

Meng Jiang China

Lingli Li China

Jianyi Dai China

Raffaela Di Napoli Italy

Xiangao Jiang China

Manish Bansal India

Christine Shing-Yen Lo China

Scott C. Dulebohn United States

Rui Han China

Nannan Shi

576 ×0.7

RNMI

579 ×0.7

359 ×1.2

NEURO

151 ×0.7

ONCOL

105 ×0.5

Citations per year, relative to Nannan Shi Nannan Shi (= 1×) peers Rui Han

Countries citing papers authored by Nannan Shi

Since Specialization

Citations

This map shows the geographic impact of Nannan Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nannan Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nannan Shi more than expected).

Fields of papers citing papers by Nannan Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nannan Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nannan Shi. The network helps show where Nannan Shi may publish in the future.

Co-authorship network of co-authors of Nannan Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Nannan Shi. A scholar is included among the top collaborators of Nannan Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nannan Shi. Nannan Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Nannan, et al.. (2024). Seismic metamaterial design prediction based on joint neural network. Materials Today Communications. 41. 111001–111001. 1 indexed citations

Tian, Song, Jing Guo, Bin Liu, et al.. (2024). Trends in symptom prevalence and sequential onset of SARS-CoV-2 infection from 2020 to 2022 in East and Southeast Asia: a trajectory pattern exploration based on summary data. Archives of Public Health. 82(1). 125–125.

Guo, Jing, Bin Liu, Song Tian, et al.. (2024). Mechanisms of immune response and cell death in ischemic stroke and their regulation by natural compounds. Frontiers in Immunology. 14. 1287857–1287857. 41 indexed citations

Shi, Nannan, et al.. (2024). Artificial intelligence for the detection of glaucoma with SD-OCT images: a systematic review and Meta-analysis. International Journal of Ophthalmology. 17(3). 408–419. 5 indexed citations

Tian, Song, Mingzhi Hu, Jing Guo, et al.. (2024). Natural and socio-environmental factors in the transmission of COVID-19: a comprehensive analysis of epidemiology and mechanisms. BMC Public Health. 24(1). 2196–2196. 4 indexed citations

Zhao, Chen, Ning Liang, Haili Zhang, et al.. (2023). Harnessing the power of clinical decision support systems: challenges and opportunities. Open Heart. 10(2). e002432–e002432. 69 indexed citations

He, Mei-yao, Ping Zhang, Nannan Shi, et al.. (2023). Nrf2 Is Involved in Hyperglycemia-induced Abnormal Lung Development through both Antioxidation-Dependent and Antioxidation-Independent Activation. American Journal of Respiratory Cell and Molecular Biology. 69(2). 197–209. 4 indexed citations

Liang, Ning, et al.. (2023). Dazhu Hongjingtian Injection for Ischemic Stroke: Protocol for a Prospective, Multicenter Observational Study. JMIR Research Protocols. 12. e52447–e52447. 2 indexed citations

Zhao, Chen, et al.. (2023). Advancements and implications of semantic reconstruction of continuous language from non‐invasive brain recordings. SHILAP Revista de lepidopterología. 1(3). 2 indexed citations

10.

Ma, Yan, Nannan Shi, Lin Tong, et al.. (2022). Effect of Qingfei Paidu decoction combined with Western medicine treatments for COVID-19: A systematic review and meta-analysis. Phytomedicine. 102. 154166–154166. 14 indexed citations

11.

Zhu, Hongfei, Mengting Li, Honghao Lai, et al.. (2022). Efficacy and safety of chinese herbal medicine for treating mild or moderate COVID-19: A systematic review and meta-analysis of randomized controlled trials and observational studies. Frontiers in Pharmacology. 13. 988237–988237. 8 indexed citations

12.

Shi, Nannan, et al.. (2021). A combined quality evaluation method that integrates chemical constituents, appearance traits and origins of raw Rehmanniae Radix pieces. Chinese Journal of Natural Medicines. 19(7). 551–560. 9 indexed citations

13.

Li, Qingtao, Tianyou Chen, Nannan Shi, et al.. (2021). Quantitative evaluation of hepatic fibrosis by fibro Scan and Gd-EOB-DTPA-enhanced T1 mapping magnetic resonance imaging in chronic hepatitis B. Abdominal Radiology. 47(2). 684–692. 9 indexed citations

14.

Liang, Ning, et al.. (2021). Diagnosis and Treatment for Mild Cognitive Impairment: A Systematic Review of Clinical Practice Guidelines and Consensus Statements. Frontiers in Neurology. 12. 719849–719849. 84 indexed citations

15.

Liu, Fengjun, Qi Zhang, Chao Huang, et al.. (2020). CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Theranostics. 10(12). 5613–5622. 138 indexed citations

16.

Jin, Mingming, Nannan Shi, Meng Wang, et al.. (2020). CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients. Aging. 12(20). 19867–19879. 18 indexed citations

17.

Shi, Nannan, Fengxiang Song, Fengjun Liu, et al.. (2020). Preliminary investigation of relationship between clinical indicators and CT manifestation patterns of COVID-19 pneumonia improvement. Journal of Thoracic Disease. 12(10). 5896–5905. 1 indexed citations

18.

Shi, Nannan, Linda L. D. Zhong, Chi Zhang, et al.. (2016). Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process. European Journal of Integrative Medicine. 8(6). 916–920. 1 indexed citations

19.

Shi, Nannan, et al.. (2012). Adoption in China of Clinical Practice Guidelines for Hypertension Using Traditional Chinese Medical Approaches: A Literature Review Based on Clinical Studies. The Journal of Alternative and Complementary Medicine. 19(1). 1–8. 22 indexed citations

20.

Shi, Nannan, et al.. (2012). Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China. Chinese Journal of Integrative Medicine. 18(2). 112–119. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact